Topical Rapamycin Therapy to Alleviate the Cutaneous Manifestations of Tuberous Sclerosis Complex

A Novel Application of Topical Rapamycin Formulation, an Inhibitor of mTOR, for Patients With Hypomelanotic Macules in Tuberous Sclerosis Complex

(2012) Mari Wataya-Kaneda   ARCHIVES OF DERMATOLOGY

Dramatic Improvement of Facial Angiofibromas in Tuberous Sclerosis With Topical Rapamycin: Optimizing a Treatment Protocol

(2011) Cynthia M. C. DeKlotz   ARCHIVES OF DERMATOLOGY

Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: A pilot study of four patients

(2011) Rachael S Foster et al.   AUSTRALASIAN JOURNAL OF DERMATOLOGY

A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity

(2011) M. Wataya-Kaneda et al.   BRITISH JOURNAL OF DERMATOLOGY

Treatment of facial angiofibromas with topical application of oral rapamycin solution (1 mg mL−1) in two patients with tuberous sclerosis

(2011) M.M. Mutizwa et al.   BRITISH JOURNAL OF DERMATOLOGY

Topical Rapamycin

(2010) Anna K. Haemel et al.   ARCHIVES OF DERMATOLOGY

Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin

(2010) Elizabeth Kaufman McNamara et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Lymphangioleiomyomatosis (LAM): Molecular insights lead to targeted therapies

(2010) Connie G. Glasgow et al.   RESPIRATORY MEDICINE

Regression of Subependymal Giant Cell Astrocytoma With Rapamycin in Tuberous Sclerosis Complex

(2008) Mary Kay Koenig et al.   JOURNAL OF CHILD NEUROLOGY

Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis

(2008) John J. Bissler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas

(2008) S. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA